Put Options

23 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$187.96 - $245.29 $1.9 Million - $2.48 Million
10,100 Added 87.07%
21,700 $4.27 Million
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $763,643 - $994,301
3,700 Added 46.84%
11,600 $2.4 Million
Q1 2024

May 15, 2024

SELL
$203.52 - $273.43 $305,280 - $410,145
-1,500 Reduced 15.96%
7,900 $2.14 Million
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $279,684 - $406,028
1,700 Added 22.08%
9,400 $2.22 Million
Q3 2023

Nov 15, 2023

BUY
$194.44 - $217.61 $544,432 - $609,308
2,800 Added 57.14%
7,700 $1.51 Million
Q2 2023

Aug 23, 2023

BUY
$183.71 - $210.25 $900,179 - $1.03 Million
4,900 New
4,900 $1.03 Million
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $197,110 - $250,070
1,000 Added 29.41%
4,400 $959,000
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $91,220 - $125,270
500 Added 17.24%
3,400 $646,000
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $877,759 - $1.3 Million
-4,300 Reduced 59.72%
2,900 $636,000
Q1 2022

May 16, 2022

SELL
$255.51 - $362.11 $945,387 - $1.34 Million
-3,700 Reduced 33.94%
7,200 $2.09 Million
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $1.09 Million - $1.39 Million
-3,100 Reduced 22.14%
10,900 $4.1 Million
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $2.31 Million - $2.84 Million
6,200 Added 79.49%
14,000 $5.92 Million
Q2 2021

Aug 06, 2021

BUY
$294.17 - $371.65 $1.15 Million - $1.45 Million
3,900 Added 100.0%
7,800 $2.9 Million
Q1 2021

May 14, 2021

BUY
$249.67 - $299.48 $674,109 - $808,596
2,700 Added 225.0%
3,900 $1.12 Million
Q4 2020

Feb 12, 2021

SELL
$222.0 - $252.62 $399,600 - $454,716
-1,800 Reduced 60.0%
1,200 $298,000
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $1.42 Million - $1.83 Million
-8,100 Reduced 72.97%
3,000 $669,000
Q2 2020

Aug 13, 2020

BUY
$118.84 - $189.72 $297,100 - $474,300
2,500 Added 29.07%
11,100 $1.88 Million
Q1 2020

May 11, 2020

BUY
$98.9 - $178.34 $395,600 - $713,360
4,000 Added 86.96%
8,600 $1.12 Million
Q4 2019

Feb 12, 2020

SELL
$126.05 - $152.76 $63,025 - $76,380
-500 Reduced 9.8%
4,600 $698,000
Q3 2019

Nov 14, 2019

BUY
$125.07 - $143.67 $637,857 - $732,716
5,100 New
5,100 $676,000
Q3 2018

Nov 14, 2018

SELL
$112.11 - $134.54 $482,073 - $578,522
-4,300 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$98.19 - $115.2 $19,638 - $23,040
200 Added 4.88%
4,300 $459,000
Q4 2017

Feb 14, 2018

BUY
$100.43 - $118.09 $411,763 - $484,169
4,100
4,100 $449,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.48B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.